• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拭子、灌洗液和稀释剂定量检测女性生殖道可溶性黏膜介质生物标志物的性能。

Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators.

机构信息

Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.

出版信息

PLoS One. 2011;6(8):e23136. doi: 10.1371/journal.pone.0023136. Epub 2011 Aug 12.

DOI:10.1371/journal.pone.0023136
PMID:21858008
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3155537/
Abstract

BACKGROUND

Measurement of immune mediators and antimicrobial activity in female genital tract secretions may provide biomarkers predictive of risk for HIV-1 acquisition and surrogate markers of microbicide safety. However, optimal methods for sample collection do not exist. This study compared collection methods.

METHODS

Secretions were collected from 48 women (24 with bacterial vaginosis [BV]) using vaginal and endocervical Dacron and flocked swabs. Cervicovaginal lavage (CVL) was collected with 10 mL of Normosol-R (n = 20), saline (n = 14), or water (n = 14). The concentration of gluconate in Normosol-R CVL was determined to estimate the dilution factor. Cytokine and antimicrobial mediators were measured by Luminex or ELISA and corrected for protein content. Endogenous anti-HIV-1 and anti-E. coli activity were measured by TZM-bl assay or E. coli growth.

RESULTS

Higher concentrations of protein were recovered by CVL, despite a 10-fold dilution of secretions, as compared to swab eluents. After protein correction, endocervical swabs recovered the highest mediator levels regardless of BV status. Endocervical and vaginal flocked swabs recovered significantly higher levels of anti-HIV-1 and anti-E. coli activity than Dacron swabs (P<0.001). BV had a significant effect on CVL mediator recovery. Normosol-R tended to recover higher levels of most mediators among women with BV, whereas saline or water tended to recover higher levels among women without BV. Saline recovered the highest levels of anti-HIV-1 activity regardless of BV status.

CONCLUSIONS

Endocervical swabs and CVL collected with saline provide the best recovery of most mediators and would be the optimal sampling method(s) for clinical trials.

摘要

背景

测量女性生殖道分泌物中的免疫介质和抗菌活性可能提供预测 HIV-1 感染风险的生物标志物和杀微生物剂安全性的替代标志物。然而,目前不存在最佳的样本采集方法。本研究比较了不同的采集方法。

方法

使用阴道和宫颈 Dacron 和纤维拭子收集 48 名女性(24 名患有细菌性阴道病 [BV])的分泌物。使用 10mL 的 Normosol-R(n=20)、生理盐水(n=14)或水(n=14)进行宫颈阴道灌洗(CVL)。测定 Normosol-R CVL 中葡萄糖酸盐的浓度以估计稀释因子。通过 Luminex 或 ELISA 测量细胞因子和抗菌介质,并根据蛋白含量进行校正。通过 TZM-bl 测定或大肠杆菌生长来测量内源性抗 HIV-1 和抗大肠杆菌活性。

结果

与拭子洗脱液相比,CVL 尽管将分泌物稀释了 10 倍,但仍能回收更高浓度的蛋白。经蛋白校正后,无论 BV 状态如何,宫颈拭子均能回收最高的介质水平。宫颈和阴道纤维拭子比 Dacron 拭子回收的抗 HIV-1 和抗大肠杆菌活性显著更高(P<0.001)。BV 对 CVL 介质的回收有显著影响。在患有 BV 的女性中,Normosol-R 倾向于回收更高水平的大多数介质,而在没有 BV 的女性中,生理盐水或水倾向于回收更高水平的介质。生理盐水无论 BV 状态如何,均能回收最高水平的抗 HIV-1 活性。

结论

宫颈拭子和用生理盐水采集的 CVL 能最好地回收大多数介质,是临床试验的最佳采样方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ce6/3155537/8b19334e0d79/pone.0023136.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ce6/3155537/712d626406f0/pone.0023136.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ce6/3155537/436132f7d67b/pone.0023136.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ce6/3155537/fb209e295663/pone.0023136.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ce6/3155537/c95c1c7b87df/pone.0023136.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ce6/3155537/8b19334e0d79/pone.0023136.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ce6/3155537/712d626406f0/pone.0023136.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ce6/3155537/436132f7d67b/pone.0023136.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ce6/3155537/fb209e295663/pone.0023136.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ce6/3155537/c95c1c7b87df/pone.0023136.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ce6/3155537/8b19334e0d79/pone.0023136.g005.jpg

相似文献

1
Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators.拭子、灌洗液和稀释剂定量检测女性生殖道可溶性黏膜介质生物标志物的性能。
PLoS One. 2011;6(8):e23136. doi: 10.1371/journal.pone.0023136. Epub 2011 Aug 12.
2
A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gel.一项评估 1%替诺福韦凝胶应用后女性生殖道分泌物和可溶性黏膜免疫中抗 HIV 活性的随机试验。
PLoS One. 2011 Jan 25;6(1):e16475. doi: 10.1371/journal.pone.0016475.
3
Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal Immunity.细菌性阴道病与生殖道炎症和黏膜免疫的亚临床标志物
AIDS Res Hum Retroviruses. 2015 Nov;31(11):1139-52. doi: 10.1089/aid.2015.0006. Epub 2015 Jul 23.
4
Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.撒哈拉以南非洲女性特定生殖道免疫标志物与阴道微生物群的横断面分析及其与艾滋病病毒风险和预防的相关性
Clin Vaccine Immunol. 2015 May;22(5):526-38. doi: 10.1128/CVI.00762-14. Epub 2015 Mar 11.
5
Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection.乳铁蛋白、分泌型白细胞蛋白酶抑制剂及调节激活正常T细胞表达和分泌因子在人免疫缺陷病毒(HIV)血清学阴性、有异性感染HIV高风险女性中的宫颈阴道水平及合并阴道疾病的影响
Clin Vaccine Immunol. 2007 Sep;14(9):1102-7. doi: 10.1128/CVI.00386-06. Epub 2007 Aug 1.
6
Differential profiles of immune mediators and in vitro HIV infectivity between endocervical and vaginal secretions from women with Chlamydia trachomatis infection: a pilot study.沙眼衣原体感染女性的宫颈和阴道分泌物中免疫介质和体外 HIV 感染率的差异特征:一项初步研究。
J Reprod Immunol. 2013 Sep;99(1-2):80-7. doi: 10.1016/j.jri.2013.07.003. Epub 2013 Aug 8.
7
Levels of Genital Tract Defensins and Cytokines Differ between HIV-Uninfected US and African Women.未感染艾滋病毒的美国女性和非洲女性生殖道防御素及细胞因子水平存在差异。
Am J Reprod Immunol. 2015 Oct;74(4):313-22. doi: 10.1111/aji.12411. Epub 2015 Jun 21.
8
Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage.比较月经杯和宫颈阴道灌洗获取的女性生殖道分泌物中HIV-1特异性抗体和细胞因子浓度的随机横断面研究。
PLoS One. 2015 Jul 6;10(7):e0131906. doi: 10.1371/journal.pone.0131906. eCollection 2015.
9
Comparison of techniques for HIV-1 RNA detection and quantitation in cervicovaginal secretions.宫颈阴道分泌物中HIV-1 RNA检测和定量技术的比较
J Acquir Immune Defic Syndr. 2001 Feb 1;26(2):170-5. doi: 10.1097/00042560-200102010-00010.
10
The impact of pregnancy on anti-HIV activity of cervicovaginal secretions.妊娠对宫颈阴道分泌物抗HIV活性的影响。
Am J Obstet Gynecol. 2016 Dec;215(6):748.e1-748.e12. doi: 10.1016/j.ajog.2016.06.057. Epub 2016 Jul 5.

引用本文的文献

1
Metabolic comparison of minimally to noninvasive urogenital sample types for studying gynecologic health: A pilot study.用于研究妇科健康的微创与非侵入性泌尿生殖样本类型的代谢比较:一项初步研究。
iScience. 2025 Jun 18;28(7):112938. doi: 10.1016/j.isci.2025.112938. eCollection 2025 Jul 18.
2
MicroRNA-Based Liquid Biopsy for Cervical Cancer Diagnostics and Treatment Monitoring.基于微小RNA的液体活检用于宫颈癌诊断和治疗监测
Int J Mol Sci. 2024 Dec 10;25(24):13271. doi: 10.3390/ijms252413271.
3
Possible Therapeutic Mechanisms and Future Perspectives of Vaginal Microbiota Transplantation.

本文引用的文献

1
Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women.BufferGel 和 0.5% PRO2000 凝胶预防女性 HIV 感染的安全性和有效性。
AIDS. 2011 Apr 24;25(7):957-66. doi: 10.1097/QAD.0b013e32834541d9.
2
A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gel.一项评估 1%替诺福韦凝胶应用后女性生殖道分泌物和可溶性黏膜免疫中抗 HIV 活性的随机试验。
PLoS One. 2011 Jan 25;6(1):e16475. doi: 10.1371/journal.pone.0016475.
3
Estimating volume of cervicovaginal secretions in cervicovaginal lavage fluid collected for measurement of genital HIV-1 RNA levels in women.
阴道微生物群移植的可能治疗机制及未来展望
Microorganisms. 2023 May 29;11(6):1427. doi: 10.3390/microorganisms11061427.
4
Comparative analysis of vaginal microbiota sampling using menstrual cups and high vaginal swabs in pregnant women living with HIV-1 infection.比较分析在 HIV-1 感染孕妇中使用月经杯和阴道拭子进行阴道微生物群采样。
Front Cell Infect Microbiol. 2023 May 9;13:1190160. doi: 10.3389/fcimb.2023.1190160. eCollection 2023.
5
Interactions between microbiota and cervical epithelial, immune, and mucus barrier.微生物群与宫颈上皮、免疫和黏液屏障的相互作用。
Front Cell Infect Microbiol. 2023 Feb 24;13:1124591. doi: 10.3389/fcimb.2023.1124591. eCollection 2023.
6
Considerations for Choosing Soluble Immune Markers to Determine Safety of Novel Vaginal Products.选择可溶性免疫标志物以确定新型阴道产品安全性的考量因素。
Front Reprod Health. 2022 May 17;4:899277. doi: 10.3389/frph.2022.899277. eCollection 2022.
7
Starting to have sexual intercourse is associated with increases in cervicovaginal immune mediators in young women: a prospective study and meta-analysis.开始性行为与年轻女性宫颈阴道免疫介质的增加有关:一项前瞻性研究和荟萃分析。
Elife. 2022 Oct 25;11:e78565. doi: 10.7554/eLife.78565.
8
Changes in concentrations of cervicovaginal immune mediators across the menstrual cycle: a systematic review and meta-analysis of individual patient data.月经周期中宫颈阴道免疫介质浓度的变化:一项基于个体患者数据的系统评价和荟萃分析。
BMC Med. 2022 Oct 5;20(1):353. doi: 10.1186/s12916-022-02532-9.
9
Sexual violence history predicts changes in vaginal immune parameters during sexual arousal.性暴力史可预测性唤起过程中阴道免疫参数的变化。
Brain Behav Immun. 2022 Aug;104:171-180. doi: 10.1016/j.bbi.2022.06.005. Epub 2022 Jun 10.
10
Interferon epsilon and preterm birth subtypes; a new piece of the type I interferon puzzle during pregnancy?干扰素 ε 和早产亚型;妊娠期间 I 型干扰素之谜的新线索?
Am J Reprod Immunol. 2022 Apr;87(4):e13526. doi: 10.1111/aji.13526. Epub 2022 Feb 26.
估算用于测量女性生殖道 HIV-1 RNA 水平的宫颈阴道灌洗液中宫颈阴道分泌物的体积。
J Clin Microbiol. 2011 Feb;49(2):735-6. doi: 10.1128/JCM.00991-10. Epub 2010 Nov 24.
4
Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota.1型人类免疫缺陷病毒的宫颈阴道脱落与生殖道炎症相关,与阴道微生物群的变化无关。
AIDS Res Hum Retroviruses. 2011 Jan;27(1):35-9. doi: 10.1089/aid.2010.0129. Epub 2010 Oct 7.
5
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.PRO2000 阴道凝胶预防 HIV-1 感染(杀微生物剂开发计划 301):一项 3 期、随机、双盲、平行组试验。
Lancet. 2010 Oct 16;376(9749):1329-37. doi: 10.1016/S0140-6736(10)61086-0. Epub 2010 Sep 17.
6
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.替诺福韦凝胶作为一种抗逆转录病毒的杀微生物剂,用于预防女性感染艾滋病毒的有效性和安全性。
Science. 2010 Sep 3;329(5996):1168-74. doi: 10.1126/science.1193748. Epub 2010 Jul 19.
7
Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies.HIV 阳性和阴性女性宫颈阴道分泌物中的抗 HIV 活性与先天抗菌水平和 IgG 抗体相关。
PLoS One. 2010 Jun 29;5(6):e11366. doi: 10.1371/journal.pone.0011366.
8
Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections.特定型别的宫颈阴道人乳头瘤病毒感染增加了 HIV 获得的风险,而与其他性传播感染无关。
PLoS One. 2010 Apr 8;5(4):e10094. doi: 10.1371/journal.pone.0010094.
9
Assessment of mucosal immunity to HIV-1.评估 HIV-1 黏膜免疫。
Expert Rev Vaccines. 2010 Apr;9(4):381-94. doi: 10.1586/erv.10.21.
10
Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens.性激素对女性生殖道固有免疫的调节:上皮细胞在平衡生殖潜能与预防性传播病原体之间的作用。
Am J Reprod Immunol. 2010 Jun;63(6):544-65. doi: 10.1111/j.1600-0897.2010.00842.x. Epub 2010 Mar 29.